A Pilot Multicenter, Randomized, Double-Blind Study Comparing The Proportion Of Responders to PSD502 and to Placebo Using the PEBEQ In Subjects With Premature Ejaculation
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2019
At a glance
- Drugs Lidocaine/prilocaine (Primary)
- Indications Premature ejaculation
- Focus Therapeutic Use
- Sponsors Plethora Solutions
- 14 Jan 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Dec 2018 to 1 Jan 2019.
- 06 Dec 2018 Status changed from not yet recruiting to recruiting.
- 29 Nov 2018 Planned End Date changed from 1 Oct 2019 to 1 Mar 2020.